| DIG(N = 265) | EIG(N = 179) | P value |
---|---|---|---|
Age: years (IQR) | 33(27–42) | 32(27–40) | 0.276 |
Male: no. (%) | 199(75.1) | 125 (69.8) | 0.232 |
Ethnicity:no. (%) | |||
 Han | 195(73.6) | 123(68.1) | 0.284 |
 Other | 70 (26.4) | 56 (31.9) |  |
Mode of HIV acquisition: no. (%) | |||
 MSM | 92 (34.7%) | 63 (35.2%) | 0.920 |
  Heterosexual | 142 (53.6%) | 98 (54.7%) | 0.846 |
  Bisexual | 6 (2.3%) | 6 (3.4%) | 0.557 |
  Blood products | 2 (0.4%) | 1 (0.6%) | 1.000 |
  Other/undefined | 14 (9.3%) | 11 (5.5%) | 0.682 |
HIV-1 subtype | |||
 AE | 125 (47.2%) | 60 (33.5%) | 0.004 |
 B/C/BC | 69 (26.0%) | 63 (35.2%) | 0.044 |
  unknown | 71 (26.8%) | 56 (31.3%) | 0.336 |
CD4 count: (cells/mm3) | 239 (161–292) | 401 (376–451) | < 0.001 |
CD4/CD8 ratio: | 0.25 (0.19–0.39) | 0.39 (0.24–0.45) | 0.001 |
HIV-1 RNA: (log10 copies/mL) | 4.83 (4.43–5.14) | 4.66 (4.39–5.05) | 0.641 |
HIV-1 DNA: (log10 copies /106PBMCs) | 3.00 (2.65–3.39) | 2.73 (2.40–3.03) | < 0.001 |
HBsAg (+): no. (%) | 27 (10.2%) | 18 (10.1%) | 1.000 |
HCV-Ab (+): no. (%) | 9 (3.4%) | 4 (2.2%) | 0.579 |